Guide price only. Final cost is confirmed after assessment.
At London Cartilage Clinic, we are at the forefront of meniscus regeneration, offering state-of-the-art treatments for meniscus injuries - one of the most common injuries that result in functional impairment in the knee.
Reviewed byProf Paul Lee MBBch, FRCS (Tr & Orth), PhDLast reviewed 1 May 2026
The meniscus helps absorb impact and stabilise the knee. When it is damaged, everyday movement, exercise, and sport can become painful or unreliable.
Our focus is to preserve meniscal tissue where possible and improve the biological environment for healing, helping you stay active for longer.
Common symptoms include pain, swelling, clicking, and loss of confidence in the knee. We combine clinical assessment with MRI to define tear pattern, tissue quality, and joint alignment before recommending treatment.
Your pathway is personalised and may combine rehabilitation, targeted injection therapy, or surgery depending on symptoms, goals, and scan findings.
With specialist meniscus expertise, we focus on durable symptom relief and safer return to daily activity and sport.
Meniscus regeneration involves using regenerative medicine techniques to heal and reconstruct damaged meniscal tissue.
Treatments include MFAT, BMAC, and PRP therapy, among others.
Diagnosis typically combines specialist clinical examination with MRI. X-rays can help assess bone and joint alignment but do not directly diagnose meniscus tears; arthroscopy may be used in selected cases.
Yes, including medications, physiotherapy, and lifestyle changes.
Still have more specific concerns?
Free Discovery CallLondon Cartilage Clinic
Clinical updates, cartilage treatment guidance, and recovery-focused articles from our specialist team.
A collagen scaffold injected under ultrasound recruits the body's own progenitor cells to rebuild shoulder cartilage. Evidence from other joints shows 70–85% of patients achieve symptom relief at three to five years, though shoulder-specific randomised controlled trial data do not yet exist.
The collagen scaffold in ChondroFiller injection works by recruiting repair cells from subchondral bone; lesions must therefore penetrate at least half the cartilage thickness, and candidacy depends on whether damage is focal (up to 6 cm²) or diffuse.
Advanced knee osteoarthritis typically damages two anatomically separate compartments — the articular cartilage surface and the synovial lining — simultaneously, yet most single-injection treatments address only one. A dual-injection protocol combines ChondroFiller, which scaffolds cartilage, with Arthrosamid, which cushions the synovial membrane.
